Published in Am J Clin Nutr on June 01, 2006
Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ (2007) 5.99
Clinical Use of Probiotics in Pediatric Allergy (CUPPA): A World Allergy Organization Position Paper. World Allergy Organ J (2012) 1.60
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol (2010) 1.58
Routine probiotics for premature infants: let's be careful! J Pediatr (2011) 1.47
Safety assessment of probiotics for human use. Gut Microbes (2010) 1.44
Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications. Clin Exp Immunol (2007) 1.43
Assessment of bacterial antibiotic resistance transfer in the gut. Int J Microbiol (2011) 1.26
Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide. Aliment Pharmacol Ther (2013) 1.21
Risks associated with high-dose Lactobacillus rhamnosus in an Escherichia coli model of piglet diarrhoea: intestinal microbiota and immune imbalances. PLoS One (2012) 1.20
Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Crit Care (2008) 1.06
Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therap Adv Gastroenterol (2011) 1.05
Microorganisms with claimed probiotic properties: an overview of recent literature. Int J Environ Res Public Health (2014) 1.05
How patients view probiotics: findings from a multicenter study of patients with inflammatory bowel disease and irritable bowel syndrome. J Clin Gastroenterol (2012) 1.04
Prospects for the development of probiotics and prebiotics for oral applications. J Oral Microbiol (2009) 1.02
A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial. BMC Gastroenterol (2010) 1.01
Use of probiotics in gastrointestinal disorders: what to recommend? Therap Adv Gastroenterol (2010) 0.99
New advances in the treatment of Clostridium difficile infection (CDI). Ther Clin Risk Manag (2008) 0.98
Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation. PLoS One (2013) 0.97
Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med (2011) 0.97
A gastroenterologist's guide to probiotics. Clin Gastroenterol Hepatol (2012) 0.96
The interplay between fiber and the intestinal microbiome in the inflammatory response. Adv Nutr (2013) 0.95
Probiotics and periodontal health. J Med Life (2011) 0.94
Survival of Lactobacillus reuteri DSM 17938 and Lactobacillus rhamnosus GG in the human gastrointestinal tract with daily consumption of a low-fat probiotic spread. Appl Environ Microbiol (2009) 0.92
Irritable bowel syndrome: a concise review of current treatment concepts. World J Gastroenterol (2014) 0.92
Prevention and treatment of urinary tract infection with probiotics: Review and research perspective. Indian J Urol (2008) 0.90
Mycoses in the elderly. Eur J Clin Microbiol Infect Dis (2009) 0.89
Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome. PLoS Pathog (2012) 0.89
Helping patients make informed choices about probiotics: a need for research. Am J Gastroenterol (2009) 0.88
The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota. Alcohol Res (2015) 0.87
Probiotics in clostridium difficile Infection. J Clin Gastroenterol (2011) 0.86
Interaction between lactic acid bacteria and Mycobacterium bovis in Ethiopian fermented milk: insight into the fate of M. bovis. Appl Environ Microbiol (2009) 0.86
Do children's upper respiratory tract infections benefit from probiotics? BMC Infect Dis (2014) 0.86
The effect of probiotic soy milk and soy milk on anthropometric measures and blood pressure in patients with type II diabetes mellitus: A randomized double-blind clinical trial. ARYA Atheroscler (2015) 0.85
Probiotics in respiratory virus infections. Eur J Clin Microbiol Infect Dis (2014) 0.85
Topical treatment with probiotic Lactobacillus brevis CD2 inhibits experimental periodontal inflammation and bone loss. J Periodontal Res (2014) 0.84
Are probiotics safe for use during pregnancy and lactation? Can Fam Physician (2011) 0.83
Probiotics for antibiotic-associated diarrhea: do we have a verdict? World J Gastroenterol (2014) 0.83
Role of probiotics in short bowel syndrome in infants and children--a systematic review. Nutrients (2013) 0.82
Regulation of Hepatic Drug-Metabolizing Enzymes in Germ-Free Mice by Conventionalization and Probiotics. Drug Metab Dispos (2015) 0.82
Effect of probiotics on the treatment of children with atopic dermatitis. Ann Dermatol (2012) 0.82
An analysis of online messages about probiotics. BMC Gastroenterol (2013) 0.81
Interaction of Lactobacillus fermentum BGHI14 with rat colonic mucosa: implications for colitis induction. Appl Environ Microbiol (2013) 0.80
Diet and nutrition in cancer survivorship and palliative care. Evid Based Complement Alternat Med (2013) 0.80
Probiotics, prebiotics and synbiotics- a review. J Food Sci Technol (2015) 0.80
Overview of Clostridium difficile infection: implications for China. Gastroenterol Rep (Oxf) (2013) 0.79
Gastrointestinal microbiota and some children diseases: a review. Gastroenterol Res Pract (2012) 0.79
Abrupt suspension of probiotics administration may increase host pathogen susceptibility by inducing gut dysbiosis. Sci Rep (2016) 0.79
Intestinal microbiota succession and immunomodulatory consequences after introduction of Lactobacillus reuteri I5007 in neonatal piglets. PLoS One (2015) 0.79
Probiotics, fibre and herbal medicinal products for functional and inflammatory bowel disorders. Br J Pharmacol (2016) 0.78
Safety and acceptability of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum subspecies infantis 35624 in Bangladeshi infants: a phase I randomized clinical trial. BMC Complement Altern Med (2016) 0.78
Molecular Characterization and Meta-Analysis of Gut Microbial Communities Illustrate Enrichment of Prevotella and Megasphaera in Indian Subjects. Front Microbiol (2016) 0.78
Accelerated dysbiosis of gut microbiota during aggravation of DSS-induced colitis by a butyrate-producing bacterium. Sci Rep (2016) 0.78
Microbial cell components induced tolerance to flagellin-stimulated inflammation through Toll-like receptor pathways in intestinal epithelial cells. Cytokine (2012) 0.78
Probiotic supplement use among young children in Taiwan: a prospective cohort study. PLoS One (2012) 0.77
Retracted Probiotics in dentistry: A boon or sham. Dent Res J (Isfahan) (2013) 0.77
Effectiveness of Saccharomyces boulardii in a rat model of colitis. World J Gastroenterol (2012) 0.76
Use of pre-, pro- and synbiotics in patients with acute pancreatitis: a meta-analysis. World J Gastroenterol (2010) 0.76
Long-Term Use of Probiotic-Containing Yogurts Is a Safe Way to Prevent Helicobacter pylori: Based on a Mongolian Gerbil's Model. Biochem Res Int (2013) 0.76
Pyelonephritis and Bacteremia from Lactobacillus delbrueckii. Case Rep Infect Dis (2012) 0.76
Probiotics in critically ill children. F1000Res (2016) 0.76
Disruption of the colonization resistance syndrome in humans in altered habitats and its prevention. Acta Naturae (2014) 0.75
Oral Feeding of Probiotic Bifidobacterium infantis: Colonic Morphological Changes in Rat Model of TNBS-Induced Colitis. Scientifica (Cairo) (2016) 0.75
Unraveling the Differences between Gram-Positive and Gram-Negative Probiotics in Modulating Protective Immunity to Enteric Infections. Front Immunol (2017) 0.75
The effects of a probiotic formulation (Lactobacillus rhamnosus and L. helveticus) on developmental trajectories of emotional learning in stressed infant rats. Transl Psychiatry (2016) 0.75
An analysis of microbiota-targeted therapies in patients with avian influenza virus subtype H7N9 infection. BMC Infect Dis (2014) 0.75
Purified cell wall from the probiotic bacterium Lactobacillus gasseri activates systemic inflammation and, at higher doses, produces lethality in a rat model. Crit Care (2014) 0.75
Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized control trial. Ann Surg (2007) 0.75
Maternal perspectives on the use of probiotics in infants: a cross-sectional survey. BMC Complement Altern Med (2014) 0.75
Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders. J Neurogastroenterol Motil (2017) 0.75
Probiotics and Disease: A Comprehensive Summary-Part 1, Mental and Neurological Health. Integr Med (Encinitas) (2016) 0.75
Bifidobacterium bifidum OLB6378 Simultaneously Enhances Systemic and Mucosal Humoral Immunity in Low Birth Weight Infants: A Non-Randomized Study. Nutrients (2017) 0.75
Microbial therapeutic interventions. Semin Fetal Neonatal Med (2016) 0.75
Evaluation of the Probiotic Strain Bifidobacterium longum subsp. Infantis CECT 7210 Capacities to Improve Health Status and Fight Digestive Pathogens in a Piglet Model. Front Microbiol (2017) 0.75
Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes. Integr Med (Encinitas) (2017) 0.75
Early probiotic supplementation for the prevention of atopic disease in newborns-probiotics and the hygiene hypothesis-. Biosci Microflora (2011) 0.75
Integrative Medicine for Gastrointestinal Disease. Prim Care (2017) 0.75
A Perspective on the Application of Pro-/Synbiotics in Clinical Practice. Front Microbiol (2017) 0.75
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet (2013) 14.06
Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol (2011) 3.05
Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial. BMJ (2014) 2.59
Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. Am J Respir Crit Care Med (2002) 2.38
Vitamin D insufficiency is associated with challenge-proven food allergy in infants. J Allergy Clin Immunol (2013) 2.31
Atypical enteropathogenic Escherichia coli infection and prolonged diarrhea in children. Emerg Infect Dis (2006) 2.19
Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. J Allergy Clin Immunol (2011) 2.13
The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. PLoS Pathog (2010) 2.03
Can early introduction of egg prevent egg allergy in infants? A population-based study. J Allergy Clin Immunol (2010) 2.01
Identification of a novel fimbrial gene cluster related to long polar fimbriae in locus of enterocyte effacement-negative strains of enterohemorrhagic Escherichia coli. Infect Immun (2002) 2.01
Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium. Infect Immun (2006) 2.01
Diagnostic microbiologic methods in the GEMS-1 case/control study. Clin Infect Dis (2012) 1.98
Characterization and evidence of mobilization of the LEE pathogenicity island of rabbit-specific strains of enteropathogenic Escherichia coli. Mol Microbiol (2002) 1.82
Identification of a protein secretory pathway for the secretion of heat-labile enterotoxin by an enterotoxigenic strain of Escherichia coli. Proc Natl Acad Sci U S A (2002) 1.78
Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol (2008) 1.77
Hypersensitivity reactions to human papillomavirus vaccine in Australian schoolgirls: retrospective cohort study. BMJ (2008) 1.66
Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis. Am J Respir Crit Care Med (2014) 1.60
Infants aged 12 months can mount adequate serotype-specific IgG responses to pneumococcal polysaccharide vaccine. J Allergy Clin Immunol (2010) 1.59
Cytokine profiles of patients infected with Mycobacterium ulcerans and unaffected household contacts. Infect Immun (2002) 1.54
Anaphylaxis - identification, management and prevention. Aust Fam Physician (2013) 1.46
Discovery of an archetypal protein transport system in bacterial outer membranes. Nat Struct Mol Biol (2012) 1.41
Control of bacterial virulence by AraC-like regulators that respond to chemical signals. Trends Microbiol (2011) 1.32
Pathogenicity of Yersinia enterocolitica biotype 1A. FEMS Immunol Med Microbiol (2003) 1.32
A phenotypic approach for IUIS PID classification and diagnosis: guidelines for clinicians at the bedside. J Clin Immunol (2013) 1.27
Contribution of Efa1/LifA to the adherence of enteropathogenic Escherichia coli to epithelial cells. Microb Pathog (2003) 1.26
Bicarbonate-mediated transcriptional activation of divergent operons by the virulence regulatory protein, RegA, from Citrobacter rodentium. Mol Microbiol (2008) 1.24
Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007. J Allergy Clin Immunol (2009) 1.23
Acquired T-helper 1 lymphocyte anergy following infection with Mycobacterium ulcerans. Clin Infect Dis (2003) 1.23
Contribution of long polar fimbriae to the virulence of rabbit-specific enteropathogenic Escherichia coli. Infect Immun (2004) 1.20
Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacement. Emerg Infect Dis (2009) 1.18
Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum. J Nat Prod (2003) 1.17
Phasevarion mediated epigenetic gene regulation in Helicobacter pylori. PLoS One (2011) 1.13
Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol (2012) 1.12
RegA, an AraC-like protein, is a global transcriptional regulator that controls virulence gene expression in Citrobacter rodentium. Infect Immun (2008) 1.11
Characterisation of atypical enteropathogenic E. coli strains of clinical origin. BMC Microbiol (2009) 1.11
The H-NS protein represses transcription of the eltAB operon, which encodes heat-labile enterotoxin in enterotoxigenic Escherichia coli, by binding to regions downstream of the promoter. Microbiology (2005) 1.10
Factors that explain excretion of enteric pathogens by persons without diarrhea. Clin Infect Dis (2012) 1.09
Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer. Neuro Oncol (2004) 1.09
Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infect Immun (2007) 1.07
Enteric pathogens, intestinal permeability and nitric oxide production in acute gastroenteritis. Pediatr Infect Dis J (2002) 1.03
Relaxin deficiency in mice is associated with an age-related progression of pulmonary fibrosis. FASEB J (2002) 1.03
Transcriptional regulation of the yghJ-pppA-yghG-gspCDEFGHIJKLM cluster, encoding the type II secretion pathway in enterotoxigenic Escherichia coli. J Bacteriol (2006) 1.02
The regulation of fibrosis in airway remodeling in asthma. Mol Cell Endocrinol (2012) 1.02
The Australasian Society of Clinical Immunology and Allergy position statement: Summary of allergy prevention in children. Med J Aust (2005) 1.02
Resveratrol has protective effects against airway remodeling and airway hyperreactivity in a murine model of allergic airways disease. Pathobiol Aging Age Relat Dis (2011) 1.01
Homologues of insecticidal toxin complex genes in Yersinia enterocolitica biotype 1A and their contribution to virulence. Infect Immun (2005) 1.01
Nasopharyngeal microbial interactions in the era of pneumococcal conjugate vaccination. Vaccine (2013) 1.00
Invasion of epithelial cells by locus of enterocyte effacement-negative enterohemorrhagic Escherichia coli. Infect Immun (2005) 1.00
Polyclonal and allergen-induced cytokine responses in adults with asthma: resolution of asthma is associated with normalization of IFN-gamma responses. J Allergy Clin Immunol (2002) 0.99
The type II secretion system and its ubiquitous lipoprotein substrate, SslE, are required for biofilm formation and virulence of enteropathogenic Escherichia coli. Infect Immun (2012) 0.99
Fimbrial adhesins produced by atypical enteropathogenic Escherichia coli strains. Appl Environ Microbiol (2011) 0.99
Effects of inner ear trauma on the risk of pneumococcal meningitis. Arch Otolaryngol Head Neck Surg (2007) 0.98
A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium. Cell Microbiol (2007) 0.98
Assembly of the type II secretion system such as found in Vibrio cholerae depends on the novel Pilotin AspS. PLoS Pathog (2013) 0.98
Pneumococcal meningitis threshold model: A potential tool to assess infectious risk of new or existing inner ear surgical interventions. Otol Neurotol (2006) 0.98
Bicarbonate-mediated stimulation of RegA, the global virulence regulator from Citrobacter rodentium. J Mol Biol (2009) 0.97
The relentless evolution of pathogenic Escherichia coli. Clin Infect Dis (2005) 0.97
Characterisation of Shiga toxin-producing Escherichia coli O157 strains isolated from humans in Argentina, Australia and New Zealand. BMC Microbiol (2008) 0.97
Effect of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian children. J Clin Microbiol (2011) 0.96
Virulence regulation in Citrobacter rodentium: the art of timing. Microb Biotechnol (2009) 0.96
Is caesarean delivery associated with sensitization to food allergens and IgE-mediated food allergy: a systematic review. Pediatr Allergy Immunol (2008) 0.96
Perinatal maternal administration of Lactobacillus paracasei NCC 2461 prevents allergic inflammation in a mouse model of birch pollen allergy. PLoS One (2012) 0.96
Multilocus sequence typing of Streptococcus pneumoniae by use of mass spectrometry. J Clin Microbiol (2011) 0.96
Contribution of the pst-phoU operon to cell adherence by atypical enteropathogenic Escherichia coli and virulence of Citrobacter rodentium. Infect Immun (2009) 0.95
Probiotic therapy as a novel approach for allergic disease. Front Pharmacol (2012) 0.95
Vaccine adjuvant properties of probiotic bacteria. Discov Med (2011) 0.95
Pneumococcal meningitis: development of a new animal model. Otol Neurotol (2006) 0.94
The development of food allergy after liver transplantation. Liver Transpl (2005) 0.94
The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants. BMC Infect Dis (2011) 0.93
Skin prick test responses and allergen-specific IgE levels as predictors of peanut, egg, and sesame allergy in infants. J Allergy Clin Immunol (2013) 0.93
Transcriptional analysis of the grlRA virulence operon from Citrobacter rodentium. J Bacteriol (2010) 0.93
Molecular epidemiology of Streptococcus pneumoniae serogroup 6 isolates from Fijian children, including newly identified serotypes 6C and 6D. J Clin Microbiol (2010) 0.92
Effect of extracellular matrix composition on airway epithelial cell and fibroblast structure: implications for airway remodeling in asthma. Ann Allergy Asthma Immunol (2009) 0.92
Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma. Cancer (2005) 0.91
Differential effects of allergen challenge on large and small airway reactivity in mice. PLoS One (2013) 0.90
Age and sex influences on airway hyperresponsiveness. J Asthma (2010) 0.90
Reactive oxygen species are the major antibacterials against Salmonella Typhimurium purine auxotrophs in the phagosome of RAW 264.7 cells. Cell Microbiol (2007) 0.90
Predetermined challenge eligibility and cessation criteria for oral food challenges in the HealthNuts population-based study of infants. J Allergy Clin Immunol (2011) 0.89
The effect of provision of an adrenaline autoinjector on quality of life in children with food allergy. J Allergy Clin Immunol (2012) 0.89
Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome. PLoS Pathog (2012) 0.89
Detection of enterohaemorrhagic Escherichia coli in patients attending hospital in Melbourne, Australia. Pathology (2004) 0.88
Transcriptional activation of the mrkA promoter of the Klebsiella pneumoniae type 3 fimbrial operon by the c-di-GMP-dependent MrkH protein. PLoS One (2013) 0.88
Assessment of the protective effect of pneumococcal vaccination in preventing meningitis after cochlear implantation. Arch Otolaryngol Head Neck Surg (2007) 0.87
The potential link between gut microbiota and IgE-mediated food allergy in early life. Int J Environ Res Public Health (2013) 0.87
Threshold shift: effects of cochlear implantation on the risk of pneumococcal meningitis. Otolaryngol Head Neck Surg (2007) 0.87
Variability in skin prick test results performed by multiple operators depends on the device used. World Allergy Organ J (2012) 0.87
Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. J Allergy Clin Immunol (2009) 0.87
The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of nonreproductive organs. Endocrinology (2006) 0.86
Prenatal administration of Lactobacillus rhamnosus has no effect on the diversity of the early infant gut microbiota. Pediatr Allergy Immunol (2011) 0.86
Mechanistic insights into the contribution of epithelial damage to airway remodeling. Novel therapeutic targets for asthma. Am J Respir Cell Mol Biol (2014) 0.86
Optimising the management of allergic rhinitis: an Australian perspective. Med J Aust (2005) 0.86
Filaggrin loss-of-function mutations do not predict food allergy over and above the risk of food sensitization among infants. J Allergy Clin Immunol (2012) 0.85
Endogenous relaxin regulates collagen deposition in an animal model of allergic airway disease. Endocrinology (2005) 0.85
Relaxin reverses airway remodeling and airway dysfunction in allergic airways disease. Endocrinology (2009) 0.85
Inhibition of Streptococcus pneumoniae adherence to human epithelial cells in vitro by the probiotic Lactobacillus rhamnosus GG. BMC Res Notes (2013) 0.84
Restriction of DNA encoding selectable markers decreases the transformation efficiency of Helicobacter pylori. FEMS Immunol Med Microbiol (2005) 0.84
Can we prevent cochlear implant recipients from developing pneumococcal meningitis? Clin Infect Dis (2008) 0.84